Basic Information
| RNALocate ID: | RLID:11002610 |
| RNA Symbol: | hsa-miR-326 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-326 |
| RNA ID: | miRBase:MIMAT0000756 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002607 | Exosome | Serum | 18589210 |
| RLID:11002608 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11002609 | Exosome | Brain tissue | 23382797 |
| RLID:11002611 | Exosome | Plasma | 24937531 |
| RLID:11002612 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000131 | Exosome | Blood | |
| RLID-D:11000433 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-mir-326 | Adult T cell leukemia | MNDR-E-MI-40140 |
| MNDR | hsa-miR-326 | Multiple sclerosis chronic progressive | MNDR-E-MI-40141 |
| MNDR | hsa-miR-326 | Large cell neuroendocrine cancer | MNDR-E-MI-40142 |
| MNDR | hsa-mir-326 | Medulloblastoma | MNDR-E-MI-40143 |
| MNDR | hsa-miR-326 | High-grade serous ovarian carcinoma | MNDR-E-MI-40144 |
| MNDR | hsa-miR-326 | Ovarian clear cell carcinoma | MNDR-E-MI-40145 |
| MNDR | hsa-miR-326 | Lymphoma | MNDR-E-MI-40146 |
| MNDR | hsa-miR-326 | Estrogen-receptor positive breast cancer | MNDR-E-MI-40147 |
| MNDR | hsa-miR-326 | Estrogen-receptor negative breast cancer | MNDR-E-MI-40148 |
| MNDR | hsa-miR-326 | Progesterone-receptor positive breast cancer | MNDR-E-MI-40149 |
| MNDR | hsa-miR-326 | Progesterone-receptor negative breast cancer | MNDR-E-MI-40150 |
| MNDR | hsa-miR-326 | Her2-receptor positive breast cancer | MNDR-E-MI-40151 |
| MNDR | hsa-mir-326 | Prostate cancer | MNDR-E-MI-40152 |
| MNDR | hsa-miR-326 | Prostate cancer | MNDR-E-MI-40153 |
| MNDR | hsa-miR-326 | Gastric cancer | MNDR-E-MI-40154 |
| MNDR | hsa-mir-326 | Gastric cancer | MNDR-E-MI-40155 |
| MNDR | hsa-miR-326 | Alzheimer disease | MNDR-E-MI-40156 |
| MNDR | hsa-mir-326 | Sickle cell diseases | MNDR-E-MI-40157 |
| MNDR | hsa-miR-326 | Esophageal carcinoma | MNDR-E-MI-40158 |
| MNDR | hsa-miR-326 | Primary biliary cirrhosis | MNDR-E-MI-40159 |
| MNDR | hsa-mir-326 | Leiomyoma | MNDR-E-MI-40160 |
| MNDR | hsa-miR-326 | Cardiovascular disease | MNDR-E-MI-40161 |
| MNDR | hsa-mir-326 | Brain cancer | MNDR-E-MI-40162 |
| MNDR | hsa-mir-326 | Lung cancer | MNDR-E-MI-40163 |
| MNDR | hsa-miR-326 | Lung cancer | MNDR-E-MI-40164 |
| MNDR | hsa-mir-326 | Parkinson disease | MNDR-E-MI-40165 |
| MNDR | hsa-miR-326 | Parkinson disease | MNDR-E-MI-40166 |
| MNDR | hsa-mir-326 | Breast cancer | MNDR-E-MI-40167 |
| MNDR | hsa-miR-326 | Breast cancer | MNDR-E-MI-40168 |
| MNDR | hsa-miR-326 | Thyroid cancer | MNDR-E-MI-40169 |
| MNDR | hsa-miR-326 | Pituitary neoplasms | MNDR-E-MI-40170 |
| MNDR | hsa-mir-326 | Pancreatic cancer | MNDR-E-MI-40171 |
| MNDR | hsa-miR-326 | Pancreatic cancer | MNDR-E-MI-40172 |
| MNDR | hsa-mir-326 | Malignant melanoma | MNDR-E-MI-40173 |
| MNDR | hsa-miR-326 | Melanoma | MNDR-E-MI-40174 |
| MNDR | hsa-miR-326 | Rectum adenocarcinoma | MNDR-E-MI-40175 |
| MNDR | hsa-miR-326 | Nephroblastoma | MNDR-E-MI-40176 |
| MNDR | hsa-miR-326 | Colon cancer | MNDR-E-MI-40177 |
| MNDR | hsa-mir-326 | Colon neoplasms | MNDR-E-MI-40178 |
| MNDR | hsa-miR-326 | Colon adenocarcinoma | MNDR-E-MI-40179 |
| MNDR | hsa-mir-326 | Multiple sclerosis | MNDR-E-MI-40180 |
| MNDR | hsa-mir-326 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-40181 |
| MNDR | hsa-miR-326 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-40182 |
| MNDR | hsa-miR-326 | Familial ovarian cancer | MNDR-E-MI-40183 |
| MNDR | hsa-mir-326 | Ovarian cancer | MNDR-E-MI-40184 |
| MNDR | hsa-miR-326 | Prostate adenocarcinoma | MNDR-E-MI-40185 |
| MNDR | hsa-miR-326 | Carcinoma ductal breast | MNDR-E-MI-40186 |
| MNDR | hsa-miR-326 | Invasive ductal carcinoma | MNDR-E-MI-40187 |
| MNDR | hsa-miR-326 | Glioblastoma | MNDR-E-MI-40188 |
| MNDR | hsa-mir-326 | Glioblastoma | MNDR-E-MI-40189 |
| MNDR | hsa-miR-326 | Astrocytoma | MNDR-E-MI-40190 |
| MNDR | hsa-mir-326 | Glioma | MNDR-E-MI-40191 |
| MNDR | hsa-miR-326 | Glioma | MNDR-E-MI-40192 |
| MNDR | hsa-mir-326 | Dermatitis atopic | MNDR-E-MI-40193 |
| MNDR | hsa-miR-326 | Amyotrophic lateral sclerosis | MNDR-E-MI-40194 |
| MNDR | hsa-miR-326 | Osteosarcoma | MNDR-E-MI-40195 |
| MNDR | hsa-mir-326 | Osteosarcoma | MNDR-E-MI-40196 |
| MNDR | hsa-miR-326 | Breast carcinoma | MNDR-E-MI-40197 |
| MNDR | hsa-miR-326 | Middle cerebral artery infarction | MNDR-E-MI-40198 |
| MNDR | hsa-miR-326 | Uterine cancer | MNDR-E-MI-40199 |
| MNDR | hsa-miR-326 | Gastric adenocarcinoma | MNDR-E-MI-40200 |
| MNDR | hsa-mir-326 | Lung fibrosis | MNDR-E-MI-40201 |
| MNDR | hsa-miR-326 | Pituitary adenoma | MNDR-E-MI-40202 |
| MNDR | hsa-miR-326 | Lung squamous cell carcinoma | MNDR-E-MI-40203 |
| MNDR | hsa-miR-326 | Lung adenocarcinoma | MNDR-E-MI-40204 |
| MNDR | hsa-miR-326 | Thyroid carcinoma | MNDR-E-MI-40205 |
| MNDR | hsa-miR-326 | Ovarian carcinoma | MNDR-E-MI-40206 |
| MNDR | hsa-miR-326 | Bladder urothelial carcinoma | MNDR-E-MI-40207 |
| MNDR | hsa-miR-326 | Pancreatic adenocarcinoma | MNDR-E-MI-40208 |
| MNDR | hsa-mir-326 | Cervical cancer | MNDR-E-MI-40209 |
| MNDR | hsa-miR-326 | Carcinoma renal cell | MNDR-E-MI-40210 |
| MNDR | hsa-miR-326 | Large cell carcinoma | MNDR-E-MI-40211 |
| MNDR | hsa-miR-326 | Cholangiocarcinoma | MNDR-E-MI-40212 |
| MNDR | hsa-mir-326 | Myelofibrosis idiopathic | MNDR-E-MI-40213 |
| MNDR | hsa-miR-326 | Esophageal cancer | MNDR-E-MI-40214 |
| MNDR | hsa-miR-326 | Lung small cell carcinoma | MNDR-E-MI-40215 |
| MNDR | hsa-mir-326 | Squamous cell carcinoma head and neck | MNDR-E-MI-40216 |
| MNDR | hsa-miR-326 | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-40217 |
| MNDR | hsa-miR-326 | Encephalomyelitis | MNDR-E-MI-40218 |
| MNDR | hsa-miR-326 | Breast invasive carcinoma | MNDR-E-MI-40219 |
| MNDR | hsa-miR-326 | Hepatocellular carcinoma | MNDR-E-MI-40220 |
| MNDR | hsa-mir-326 | Hepatocellular carcinoma | MNDR-E-MI-40221 |
| MNDR | hsa-miR-326 | Familiar ovarian carcinoma | MNDR-E-MI-40222 |
| MNDR | hsa-miR-326 | Rheumatoid arthritis | MNDR-E-MI-40223 |
| MNDR | hsa-mir-326 | Neuroblastoma | MNDR-E-MI-40224 |
| MNDR | hsa-miR-326 | Barrett's adenocarcinoma | MNDR-E-MI-40225 |
| MNDR | hsa-mir-326 | Chronic myelogenous leukemia | MNDR-E-MI-40226 |
| MNDR | hsa-mir-326 | Hodgkin lymphoma | MNDR-E-MI-40227 |
| MNDR | hsa-miR-326 | Hodgkin lymphoma | MNDR-E-MI-40228 |
| MNDR | hsa-miR-326 | Burkitt lymphoma | MNDR-E-MI-40229 |
| MNDR | hsa-miR-326 | Tonsil cancer | MNDR-E-MI-40230 |
| MNDR | hsa-miR-326 | Neuromyelitis optica | MNDR-E-MI-40231 |
| MNDR | hsa-miR-326 | Psoriasis | MNDR-E-MI-40232 |
| MNDR | hsa-miR-326 | Skin cutaneous melanoma | MNDR-E-MI-40233 |
| MNDR | hsa-miR-326 | Skin melanoma | MNDR-E-MI-40234 |
| MNDR | hsa-miR-326 | Acute myeloid leukemia | MNDR-E-MI-40235 |
| MNDR | hsa-mir-326 | Leukemia acute myeloid | MNDR-E-MI-40236 |
| MNDR | hsa-mir-326 | Colorectal cancer | MNDR-E-MI-40237 |
| MNDR | hsa-miR-326 | Colorectal cancer | MNDR-E-MI-40238 |
| MNDR | hsa-miR-326 | Nasopharynx carcinoma | MNDR-E-MI-40239 |
| MNDR | hsa-mir-326 | Multiple myeloma pathogenesis | MNDR-E-MI-40240 |
| MNDR | hsa-mir-326 | Diabetes mellitus type 1 | MNDR-E-MI-40241 |
| MNDR | hsa-mir-326 | Uterine cervical neoplasms | MNDR-E-MI-40242 |
| MNDR | hsa-miR-326 | Ependymoma | MNDR-E-MI-40243 |
| MNDR | hsa-miR-326 | Nasopharyngeal cancer | MNDR-E-MI-40244 |
| MNDR | hsa-miR-326 | Prostatic neoplasms | MNDR-E-MI-40245 |
| MNDR | hsa-miR-326 | Stroke lacunar | MNDR-E-MI-40246 |
| MNDR | hsa-miR-326 | Barrett's carcinogenesis | MNDR-E-MI-40247 |
| MNDR | hsa-miR-326 | Breast cancer her3+ negative | MNDR-E-MI-40248 |
| MNDR | hsa-mir-326 | Multiple sclerosis susceptibility | MNDR-E-MI-40249 |
| MNDR | hsa-mir-326 | Stroke susceptibility | MNDR-E-MI-40250 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA2 | Homo sapiens | RR00022408 |
TOP